Biotech Group Acquisition Corporation (BGAC)

Biotech Group Acquisition was planning to go public, but the IPO was withdrawn on Mar 26, 2024.
IPO Price
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 98.72M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 9.87M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About BGAC

Biotech Group Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of directors to focus on biotechnology companies with the potential to capitalize on the growing biotechnology sector in North America and the Asia-Pacific region (... [Read more]

Industry Shell Companies
Sector Financials
Founded 2022
Country United States
Stock Exchange NASDAQ
Ticker Symbol BGAC
Full Company Profile


Biotech Group Acquisition IPO Registration Document (S-1)

Biotech Group Acquisition has filed to go public with an IPO on the NASDAQ.

2 years ago - SEC